Humana and MemberHealth both issued profit warnings tied to lower than expected earnings from their Part D plans. The reasons are very different but the impact is the same: higher premiums from two of the biggest Medicare plans in 2009. One silver lining for advocates of the program: politically, this is a good time for Medicare plans to be struggling.
Maybe Part D isn’t such a great business for insurers after all.
After two years of almost entirely good news for big Medicare drug plan sponsors, 2008 is off to a rocky...
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Recommendations from the health technology assessment institute, NICE, reflect a strategic shift from treating type 2 diabetes to proactively preventing future complications of the condition.
Complaint names LillyDirect in action targeting the company’s free nurse and reimbursement support programs for health care providers.
The UK drug regulator has introduced several changes in recent months, such as the introduction of a decentralized manufacturing regulation. Matthew Durdy, CEO of the Cell and Gene Therapy Catapult, explains what these changes mean for the cell and gene industry.
While Japanese government announces 8-15% price cuts for four drugs, including Leqembi, industry groups urge operational improvements to national cost effectiveness assessment scheme.
The UK drug regulator has introduced several changes in recent months, such as the introduction of a decentralized manufacturing regulation. Matthew Durdy, CEO of the Cell and Gene Therapy Catapult, explains what these changes mean for the cell and gene industry.
The European Medicines Agency’s inaugural bilateral meeting with the Association of Clinical Research Organizations underscores ACRO’s commitment to advancing innovation and its presence in the EU clinical trials ecosystem.
The Medicines Control Authority of Zimbabwe has begun phasing in mandatory package labeling requirements based on GS1 identification standards. It aims to improve the traceability of medicines throughout the entire supply chain.
